0000950170-23-058472.txt : 20231102 0000950170-23-058472.hdr.sgml : 20231102 20231102210251 ACCESSION NUMBER: 0000950170-23-058472 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231102 DATE AS OF CHANGE: 20231102 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc. CENTRAL INDEX KEY: 0001773427 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39044 FILM NUMBER: 231374225 BUSINESS ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-883-9490 MAIL ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: BC SW, LP CENTRAL INDEX KEY: 0001786351 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 BUSINESS ADDRESS: STREET 1: 200 CLAREDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6175162000 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 144 1 primary_doc.xml 144 0001786351 XXXXXXXX LIVE 0001773427 SpringWorks Therapeutics, Inc. 001-39044 100 Washington Blvd. Stamford CT 06902 203-883-9490 BC SW, LP Former Affiliate Common Stock Goldman Sachs & Co. LLC

200 West Street New York NY 10282

500000 11955000 62578877 11/02/2023 Nasdaq Common Stock 09/17/2019 Automatic conversion of convertible preferred stock purchased prior to the Issuer's IPO into shares of the Issuer's Common Stock Issuer N 7131307 09/17/2019 Automatic conversion of preferred stock Common Stock 09/17/2019 Purchase of Common Stock in an underwritten public offering Underwriter N 150000 09/17/2019 Cash Y 11/02/2023 /s/ Jeffrey Schwartz, as Partner of Bain Capital Life Sciences Investors, LLC